These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 9066781)
1. Dramatic attenuation of hypusine formation on eukaryotic initiation factor 5A during senescence of IMR-90 human diploid fibroblasts. Chen ZP; Chen KY J Cell Physiol; 1997 Mar; 170(3):248-54. PubMed ID: 9066781 [TBL] [Abstract][Full Text] [Related]
2. Marked elevation of hypusine formation activity on eukaryotic initiation factor 5A in v-HA-RAS transformed mouse NIH3T3 cells. Chen ZP; Chen KY Cancer Lett; 1997 May; 115(2):235-41. PubMed ID: 9149130 [TBL] [Abstract][Full Text] [Related]
3. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Park MH; Wolff EC; Folk JE Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280 [TBL] [Abstract][Full Text] [Related]
4. The role of hypusine depletion in cytostasis induced by S-adenosyl-L-methionine decarboxylase inhibition: new evidence provided by 1-methylspermidine and 1,12-dimethylspermine. Byers TL; Lakanen JR; Coward JK; Pegg AE Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):363-8. PubMed ID: 7980394 [TBL] [Abstract][Full Text] [Related]
5. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). Park MH J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303 [TBL] [Abstract][Full Text] [Related]
6. Enantiomers of 3-methylspermidine selectively modulate deoxyhypusine synthesis and reveal important determinants for spermidine transport. Hyvönen MT; Khomutov M; Petit M; Weisell J; Kochetkov SN; Alhonen L; Vepsäläinen J; Khomutov AR; Keinänen TA ACS Chem Biol; 2015 Jun; 10(6):1417-24. PubMed ID: 25689365 [TBL] [Abstract][Full Text] [Related]
7. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma. Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the activities of variant forms of eIF-4D. The requirement for hypusine or deoxyhypusine. Park MH; Wolff EC; Smit-McBride Z; Hershey JW; Folk JE J Biol Chem; 1991 May; 266(13):7988-94. PubMed ID: 1850732 [TBL] [Abstract][Full Text] [Related]
9. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Wolff EC; Kang KR; Kim YS; Park MH Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569 [TBL] [Abstract][Full Text] [Related]
10. Higher activity of recombinant bovine deoxyhypusine synthase vs. human deoxyhypusine synthase. Huang JK; Tsai S; Huang GH; Gowda PG; Walzer AM; Wen L Protein Expr Purif; 2004 May; 35(1):32-8. PubMed ID: 15039063 [TBL] [Abstract][Full Text] [Related]
11. Deoxyhypusine synthase assay based on the use of polyhistidine-tagged substrate and metal chelate-affinity chromatography. Tao Y; Skrenta HM; Chen KY Anal Biochem; 1994 Aug; 221(1):103-8. PubMed ID: 7985780 [TBL] [Abstract][Full Text] [Related]
12. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification. Liu YP; Nemeroff M; Yan YP; Chen KY Biol Signals; 1997; 6(3):166-74. PubMed ID: 9285100 [TBL] [Abstract][Full Text] [Related]
13. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. Preukschas M; Hagel C; Schulte A; Weber K; Lamszus K; Sievert H; Pällmann N; Bokemeyer C; Hauber J; Braig M; Balabanov S PLoS One; 2012; 7(8):e43468. PubMed ID: 22927971 [TBL] [Abstract][Full Text] [Related]
14. Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine. Joe YA; Park MH J Biol Chem; 1994 Oct; 269(41):25916-21. PubMed ID: 7929297 [TBL] [Abstract][Full Text] [Related]
15. Complex formation between deoxyhypusine synthase and its protein substrate, the eukaryotic translation initiation factor 5A (eIF5A) precursor. Lee YB; Joe YA; Wolff EC; Dimitriadis EK; Park MH Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):273-81. PubMed ID: 10229683 [TBL] [Abstract][Full Text] [Related]
16. Post-translational modification of the protein-synthesis initiation factor eIF-4D by spermidine in rat hepatoma cells. Gerner EW; Mamont PS; Bernhardt A; Siat M Biochem J; 1986 Oct; 239(2):379-86. PubMed ID: 3101665 [TBL] [Abstract][Full Text] [Related]
17. Effects of inhibitors of deoxyhypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells. Chen ZP; Yan YP; Ding QJ; Knapp S; Potenza JA; Schugar HJ; Chen KY Cancer Lett; 1996 Aug; 105(2):233-9. PubMed ID: 8697449 [TBL] [Abstract][Full Text] [Related]
18. Enzyme-substrate intermediate formation at lysine 329 of human deoxyhypusine synthase. Wolff EC; Folk JE; Park MH J Biol Chem; 1997 Jun; 272(25):15865-71. PubMed ID: 9188485 [TBL] [Abstract][Full Text] [Related]
19. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer. Nakanishi S; Cleveland JL Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307 [TBL] [Abstract][Full Text] [Related]
20. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment. Park MH; Kar RK; Banka S; Ziegler A; Chung WK Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]